Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Neoplasms (Leukemia, Lymphoma, Multiple Myeloma)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02598752
What this trial is testing

Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeHematological Malignancy+3 more
Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00789776
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+13 more
Fred Hutchinson Cancer Center 41
Not applicableStudy completedNCT00534118
What this trial is testing

Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Roswell Park Cancer Institute 39
Testing effectiveness (Phase 2)Ended earlyNCT01532635
What this trial is testing

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

Who this might be right for
Hematologic MalignancyLeukemiaAcute Lymphoblastic Leukemia+9 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 4
Early research (Phase 1)Study completedNCT00513474
What this trial is testing

Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Massachusetts General Hospital 46
Testing effectiveness (Phase 2)UnknownNCT02507479
What this trial is testing

Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Who this might be right for
Non Hodgkin LymphomaHodgkin LymphomaChronic Lymphocytic Leukemia+1 more
Sheba Medical Center 24
Testing effectiveness (Phase 2)Ended earlyNCT00281879
What this trial is testing

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 200
Not applicableActive Not RecruitingNCT04537871
What this trial is testing

Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaHematopoietic and Lymphoid Cell Neoplasm+4 more
City of Hope Medical Center 350
Testing effectiveness (Phase 2)Study completedNCT00044954
What this trial is testing

Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Study completedNCT02988466
What this trial is testing

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota 78
Early research (Phase 1)Study completedNCT00521859
What this trial is testing

Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00245037
What this trial is testing

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 147
Testing effectiveness (Phase 2)Study completedNCT00003425
What this trial is testing

Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect

Who this might be right for
Breast CancerLeukemiaLymphoma+4 more
University of Kentucky 25
Early research (Phase 1)Study completedNCT00060372
What this trial is testing

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03622788
What this trial is testing

Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+10 more
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Ended earlyNCT00626626
What this trial is testing

Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation

Who this might be right for
LeukemiaMyelodysplastic SyndromeChronic Myelogenous Leukemia+3 more
Milton S. Hershey Medical Center 8
Not applicableLooking for participantsNCT07763054
What this trial is testing

Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome+6 more
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT01413568
What this trial is testing

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in RemissionChronic Myelogenous Leukemia (CML)+5 more
Polyphor Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT00881946
What this trial is testing

Repeat Dose Safety Study for Compound to Treat Hematologic Cancer

Who this might be right for
Hematologic Malignancies
Accenture 73
Large-scale testing (Phase 3)Study completedNCT01110824
What this trial is testing

Prevention of Left Ventricular Dysfunction During Chemotherapy

Who this might be right for
Acute Myeloid LeukemiaPrecursor-cell Lymphoblastic Leukemia-LymphomaLymphoid Neoplasm+3 more
Hospital Clinic of Barcelona 90
Next Page